270 related articles for article (PubMed ID: 23990173)
21. On the origin of myeloid-derived suppressor cells.
Millrud CR; Bergenfelz C; Leandersson K
Oncotarget; 2017 Jan; 8(2):3649-3665. PubMed ID: 27690299
[TBL] [Abstract][Full Text] [Related]
22. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
Sinha P; Chornoguz O; Clements VK; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
Blood; 2011 May; 117(20):5381-90. PubMed ID: 21450901
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model.
Sevko A; Michels T; Vrohlings M; Umansky L; Beckhove P; Kato M; Shurin GV; Shurin MR; Umansky V
J Immunol; 2013 Mar; 190(5):2464-71. PubMed ID: 23359505
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of PLCγ2-β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer.
Capietto AH; Kim S; Sanford DE; Linehan DC; Hikida M; Kumosaki T; Novack DV; Faccio R
J Exp Med; 2013 Oct; 210(11):2257-71. PubMed ID: 24127488
[TBL] [Abstract][Full Text] [Related]
25. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.
Zhou Z; French DL; Ma G; Eisenstein S; Chen Y; Divino CM; Keller G; Chen SH; Pan PY
Stem Cells; 2010 Mar; 28(3):620-32. PubMed ID: 20073041
[TBL] [Abstract][Full Text] [Related]
26. Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.
Hong EH; Chang SY; Lee BR; Kim YS; Lee JM; Kang CY; Kweon MN; Ko HJ
Int J Cancer; 2013 Jun; 132(12):2839-48. PubMed ID: 23184679
[TBL] [Abstract][Full Text] [Related]
27. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
[TBL] [Abstract][Full Text] [Related]
28. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL
Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068
[TBL] [Abstract][Full Text] [Related]
29. TNF signaling drives myeloid-derived suppressor cell accumulation.
Zhao X; Rong L; Zhao X; Li X; Liu X; Deng J; Wu H; Xu X; Erben U; Wu P; Syrbe U; Sieper J; Qin Z
J Clin Invest; 2012 Nov; 122(11):4094-104. PubMed ID: 23064360
[TBL] [Abstract][Full Text] [Related]
30. Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy.
Innamarato P; Kodumudi K; Asby S; Schachner B; Hall M; Mackay A; Wiener D; Beatty M; Nagle L; Creelan BC; Sarnaik AA; Pilon-Thomas S
Mol Ther; 2020 Oct; 28(10):2252-2270. PubMed ID: 32615068
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
[TBL] [Abstract][Full Text] [Related]
32. Myeloid-derived suppressor cells in transplantation and cancer.
Ochando JC; Chen SH
Immunol Res; 2012 Dec; 54(1-3):275-85. PubMed ID: 22535241
[TBL] [Abstract][Full Text] [Related]
33. Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer.
Katoh H; Watanabe M
Mediators Inflamm; 2015; 2015():159269. PubMed ID: 26078490
[TBL] [Abstract][Full Text] [Related]
34. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.
Paschall AV; Zhang R; Qi CF; Bardhan K; Peng L; Lu G; Yang J; Merad M; McGaha T; Zhou G; Mellor A; Abrams SI; Morse HC; Ozato K; Xiong H; Liu K
J Immunol; 2015 Mar; 194(5):2369-79. PubMed ID: 25646302
[TBL] [Abstract][Full Text] [Related]
35. Myeloid-Derived Suppressor Cells in Sepsis.
Schrijver IT; Théroude C; Roger T
Front Immunol; 2019; 10():327. PubMed ID: 30873175
[TBL] [Abstract][Full Text] [Related]
36. Myeloid-Derived Suppressor Cells and Proinflammatory Cytokines as Targets for Cancer Therapy.
Atretkhany KN; Drutskaya MS
Biochemistry (Mosc); 2016 Nov; 81(11):1274-1283. PubMed ID: 27914453
[TBL] [Abstract][Full Text] [Related]
37. New insights into chronic inflammation-induced immunosuppression.
Kanterman J; Sade-Feldman M; Baniyash M
Semin Cancer Biol; 2012 Aug; 22(4):307-18. PubMed ID: 22387003
[TBL] [Abstract][Full Text] [Related]
38. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
39. Myeloid-Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon?
Su Z; Ni P; Zhou C; Wang J
Scand J Immunol; 2016 Nov; 84(5):255-261. PubMed ID: 27541573
[TBL] [Abstract][Full Text] [Related]
40. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
